Skip to main content
. 2023 Feb 13;78(4):983–990. doi: 10.1093/jac/dkad032

Figure 1.

Figure 1.

In vivo efficacy of humanized regimens of cefiderocol alone and in combination with ceftazidime/avibactam, ampicillin/sulbactam and meropenem against cefiderocol non-susceptible A. baumannii after 72 h of treatment.